Gainey McKenna & Egleston has filed a class action lawsuit against Fortrea over claims that it misled investors about revenue ...

Fortrea (NASDAQ:FTRE) is a contract research organization that helps pharmaceutical, biotech, and medical device companies develop and bring their products to market through clinical trials and ...

and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly ...

Fortrea is poised to benefit from steadily increasing levels of outsourced clinical trials and complex novel therapeutics, such as biologics and gene therapies. Fortrea has extensive experience ...

Fortrea (NASDAQ:FTRE) is a contract research organization that helps pharmaceutical, biotech, and medical device companies develop and bring their products to market through clinical trials and ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Representativeness Of Pivotal Clinical Trials Disease burden information was available for 225 (232 drug-indication combinations) of the 290 drugs (appendix exhibit A3). 11 These 225 drugs ...

Clinical Trials at the Summit (CTS) 2025 brings together a diverse group of experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of achieving ...